Gibson, Dunn & Crutcher advised Alcon Inc. on the deal, and Morrison & Foerster advised OcuMension Therapeutics. OcuMension Therapeutics (“OcuMension”), a Hong Kong-listed, China-based ophthalmic pharmaceutical...
You must be a Standard 1 Year member to access this content.
Morrison Foerster advised Jamieson Laboratories Ltd. and its parent company Jamieson Wellness Inc., McCarthy Tétrault advised Jamieson Wellness, while Cleary Gottlieb and Stikeman Elliott advised DCP...
You must be a Standard 1 Year member to access this content.
Morrison Foerster and Zhong Lun advised Silver Crest Acquisition Corporation on the deal, while Kirkland & Ellis advised Tims China. TH International Limited (Tims China), the...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster LLP advised Hangzhou DAC Biotechnology Co. on the deal. Hangzhou DAC Biotechnology Co., Ltd. (“DAC Biotechnology”) announced its collaboration and license agreement with Janssen...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster advised Tate & Lyle PLC on the deal. LSE-listed Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised TH International Limited (Tims China) on the deal while Morrison & Foerster represented Silver Crest Acquisition Corporation. TH International Limited (Tims China),...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster LLP advised Triastek, Inc. on the deal. Triastek, Inc., a leading pharmaceutical company specializing in 3D printing of drug products, announced its co-development...
You must be a Standard 1 Year member to access this content.
